DURECT Corp (DRRX.OQ)

DRRX.OQ on NASDAQ Stock Exchange Global Market

1.35USD
24 Apr 2014
Price Change (% chg)

$0.00 (+0.00%)
Prev Close
$1.35
Open
$1.35
Day's High
$1.36
Day's Low
$1.31
Volume
33,661
Avg. Vol
172,250
52-wk High
$2.29
52-wk Low
$0.76

DRRX.OQ

Chart for DRRX.OQ

About

Durect Corporation is a specialty pharmaceutical company focused on the development of pharmaceutical products based on its drug delivery technology platforms. The Company’s product pipeline, as of December 31, 2012, consisted of eight investigational drug candidates in clinical development, with one program the subject of a New... (more)

Overall

Beta: 1.14
Market Cap (Mil.): $149.15
Shares Outstanding (Mil.): 110.48
Dividend: --
Yield (%): --

Financials

  DRRX.OQ Industry Sector
P/E (TTM): -- 26.72 33.52
EPS (TTM): -0.22 -- --
ROI: -74.77 -2.70 18.94
ROE: -82.09 -11.99 19.71
Search Stocks

FDA declines to approve Durect's pain drug

- U.S. Food and Drug Administration declined to approve Durect Corp's post-operative pain treatment, saying the application lacked enough data to prove the drug was safe.

12 Feb 2014

Competitors

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Pechala's Reports
$25.00
Provider: New Constructs, LLC
$25.00
Provider: S&P Capital IQ Quantitative Report
$127.00
Provider: Pechala's Reports
$15.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks